Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance-Reference-Cited by-同舟云学术

Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance

Published:2021-08-13 Issue:32 Volume:100 Page:e26911
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Jiang Yiqian,Shou Leyi,Guo Qingmin,Bao Yanhong,Xu Xiaoping,An Suhong,Lu Jianfeng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference20 articles.

1. The latest therapeutic strategies after resistance to first generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients with non-small cell lung cancer (NSCLC);Xu;Ann Transl Med,2015

2. Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors;Westover;Ann Oncol,2018

3. Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes;Offin;J Thorac Oncol,2019

4. The different path of T790M-positive EGFR-mutant lung cancer;Yoon;Ann Transl Med,2018

5. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer;Zhang;J Cancer Res Ther,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer;J CANCER RES THER;2023

2. Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases;Frontiers in Oncology;2022-11-09

3. Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2022-04-09

4. Icotinib;Reactions Weekly;2021-10